A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal.
The strategy is described in a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. If verified in an ongoing clinical trial, it could potentially help save the lives of thousands of women each year in the United States alone.
There currently are no established screening strategies for ovarian cancer. The disease often causes no specific symptoms and is difficult to detect in the early stages when it is most responsive to treatment. Therefore, ovarian cancer is highly lethal because most women have advanced disease when they are diagnosed.
Karen Lu, MD, of The University of Texas MD Anderson Cancer Center in Houston, led a team that tested the potential of a two-stage ovarian cancer screening strategy that incorporates changes in a blood protein called CA125, which is a known tumor marker. In their 11-year study, 4051 post- menopausal women initially underwent an annual CA125 blood test. Based on a calculation called the “Risk of Ovarian Cancer Algorithm,” women were divided into three groups: those who should receive another CA125 test one year later (low risk), those who should receive a repeat CA125 in three months (intermediate risk), and those who should receive a transvaginal ultrasound and be referred to a gynecologic oncologist (high risk).
An average of 5.8 percent of women were found to be of intermediate risk each year, meaning that they should receive a CA125 test in three months. The average annual referral rate to transvaginal ultrasound and review by a gynecologic oncologist was 0.9 percent. Ten women underwent surgery based on their ultrasound exams, with four having invasive ovarian cancers, two having ovarian tumors of low malignant potential, one having endometrial cancer, and three having benign ovarian tumors. This equates to a positive predictive value of 40 percent for detecting invasive ovarian cancer. The specificity of the testing strategy was 99.9 percent, meaning that only 0.1 percent of patients without cancer would be falsely identified as having the disease. Importantly, all of the ovarian cancers were early stage.
The Latest Bing News on:
Ovarian cancer
- Angle announces study of ovarian cancer CTCs using Parsortix systemon May 18, 2024 at 12:30 am
The translational study, which the research team believes is the largest study of CTCs in ovarian cancer (in terms of number of patient samples analysed), was conducted by researchers at the Medical ...
- Legislation: Insurers must pay for genetic cancer tests, follow-up screeningson May 17, 2024 at 8:08 pm
A new law in Illinois would expand access to genetic testing for people at high risk for cancer. The bill also requires insurance companies to pay for follow-up screenings. Advocates said that’s going ...
- Age, Tumor Metastasis, Surgical Treatment Contribute to Cardiovascular Mortality in Patients With Ovarian Canceron May 17, 2024 at 10:01 am
The researchers identified age, tumor metastasis, and surgical treatment as key independent prognostic factors for cardiovascular mortality in patients with ovarian cancer, highlighting the need for ...
- Florida has one of the highest rates of ovarian cancer in the nationon May 16, 2024 at 3:02 pm
Florida has one of the highest rates of ovarian cancer in the nation, and to make matters worse, ovarian cancer is the deadliest form of cancer that affects women. “We wanted to know why she got this, ...
- My ‘Bag of Tricks’ Helps Overcome Fear During Stage 4 Ovarian Canceron May 16, 2024 at 10:00 am
Ignoring fear and anxiety only allows them to grow until they explode into a full-blown anxiety attack. It’s okay to be scared about cancer progression.
- Ovarian cancer, a leading cause of death for women, explained at a Staten Island luncheonon May 15, 2024 at 4:51 pm
STATEN ISLAND, N.Y. — With World Ovarian Cancer Day observed on May 8, members of T.E.A.L. (Tell Every Amazing Lady) hosted a “Food, Fun & Facts: Ovarian Cancer and Genetics Luncheon.” The event was ...
- Ovarian cancer: CBR-5884 demonstrates promising antitumour effectson May 15, 2024 at 3:18 am
In assays and patient-derived organoids, the small molecule inhibitor CBR-5884 successfully treated epithelial ovarian cancer.
- Difference Between Ovarian Cyst And Ovarian Cancer? All You Need to Knowon May 15, 2024 at 2:57 am
Ovarian cysts can be benign (noncancerous) which are often harmless growths that commonly occur in women during their healthy reproductive years. Ovarian cancer is a malignant (cancerous) tumor, which ...
- Combined exercise and diet interventions show potential in improving ovarian cancer patients' outcomeson May 13, 2024 at 10:12 pm
A recent study in the British Journal of Cancer evaluated the impact of combined exercise and dietary intervention on fatigue, body composition, and physical function in ovarian cancer patients. The ...
- Ovarian Cancer During Pregnancy: Symptoms, Treatment, and Outlookon May 12, 2024 at 5:00 pm
Ovarian cancer can occur during pregnancy, but it’s rare. Most ovarian cancers found during pregnancy don’t cause symptoms and are at an early stage. Treatment may include surgery, chemo ...
The Latest Google Headlines on:
Ovarian cancer
[google_news title=”” keyword=”Ovarian cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Screening strategy for ovarian cancer
- Age, Tumor Metastasis, Surgical Treatment Contribute to Cardiovascular Mortality in Patients With Ovarian Canceron May 17, 2024 at 10:01 am
The researchers identified age, tumor metastasis, and surgical treatment as key independent prognostic factors for cardiovascular mortality in patients with ovarian cancer, highlighting the need for ...
- Ovarian cancer: CBR-5884 demonstrates promising antitumour effectson May 15, 2024 at 3:18 am
In assays and patient-derived organoids, the small molecule inhibitor CBR-5884 successfully treated epithelial ovarian cancer.
- Combined exercise and diet interventions show potential in improving ovarian cancer patients' outcomeson May 13, 2024 at 10:12 pm
A recent study in the British Journal of Cancer evaluated the impact of combined exercise and dietary intervention on fatigue, body composition, and physical function in ovarian cancer patients. The ...
- Breast Cancer Newson May 12, 2024 at 5:00 pm
Mar. 28, 2024 — People carrying BRCA1 and BRCA2 gene mutations are at high risk of developing breast and ovarian cancer ... Annual Breast Cancer Screening Beginning at 40 Saves Lives Feb ...
- Fredericton woman with terminal ovarian cancer warns others of riskson May 11, 2024 at 1:59 am
The "cancer that whispers" is what ovarian cancer is often called. That's because of its often subtle symptoms and a lack of effective screening for women who are at routine or low risk of ...
- World Ovarian Cancer Day: Risk factors, symptoms and preventionson May 7, 2024 at 5:09 am
World Ovarian Cancer Day is celebrated every year on May 8. The day is dedicated to raising awareness about the deadliest gynecologic cancer. According to the Journal of Ovarian Research, ovarian ...
- The biology of ovarian cancer: new opportunities for translationon April 29, 2024 at 5:00 pm
Ovarian cancer is also heterogeneous — multiple ... Despite ongoing efforts to develop an effective screening strategy (Box 1), only 20% of ovarian cancers are diagnosed while they are still ...
- Breast, ovarian cancers: DNA test, regular screening reduce mortality in women with gene mutationson April 29, 2024 at 4:12 pm
As for ovarian cancer, Prof Ngeow admitted that there are no good screening tests available. “We do recommend that once patients are done with childbearing and close to menopause, to remove the ...
- Mercy BioAnalytics to Present Results from a Large Ovarian Cancer Screening Study at the ASCO Annual Meetingon April 24, 2024 at 9:01 am
Today, there are no guideline-recommended screening tests for ovarian cancer, which kills nearly 13,000 women each year in the US alone. "Legacy technologies such as CA125 serum biomarker testing ...
- $400,000 awarded to ovarian cancer researcherson April 21, 2024 at 5:00 pm
There is still no screening test for ovarian cancer as there are for breast ... of genetic testing barriers will then be used to design supportive strategies to broaden access to cancer genetic ...
The Latest Google Headlines on:
Screening strategy for ovarian cancer
[google_news title=”” keyword=”Screening strategy for ovarian cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]